Cancer Predisposition Syndrome clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for

  • Prenatal Transplantation for Fetuses With Fanconi Anemia

    Sorry, not yet accepting patients

    The investigators aim to evaluate the safety and efficacy of in utero hematopoietic stem cell transplantation (IUHSCT) for the treatment of fetuses diagnosed with Fanconi anemia (FA) during pregnancy.

    San Francisco, California and other locations

Our lead scientists for Cancer Predisposition Syndrome research studies include .

Last updated: